Literature DB >> 8806616

Inhibition of NF-kappa B activation by panepoxydone.

G Erkel1, T Anke, O Sterner.   

Abstract

In a search for new inhibitors of NF-kappa B mediated signal transduction in COS-7 cells using the Secreted Alkaline Phosphatase as reporter gene, panepoxydone has been isolated from fermentations of the basidiomycete Lentinus crinitus. Panepoxydone inhibits the NF-kappa B activated expression of the SEAP with an IC50 of 1.5-2 micrograms/ml (7.15-9.52 microM). No inhibition of AP-1 mediated expression of the reporter gene could be observed at a concentration up to 5 micrograms/ml panepoxydone. Panepoxydone strongly reduced the TPA, TNF-alpha and ocadaic acid mediated binding of NF-kappa B to the high affinity consensus sequence in COS-7 and HeLa S3 cells as confirmed by EMSA's. Panepoxydone inhibits the I kappa B phosphorylation and therefore sequesteres the NF-kappa B complex in an inactive form.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806616     DOI: 10.1006/bbrc.1996.1335

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

2.  Discovery and characterization of a group of fungal polycyclic polyketide prenyltransferases.

Authors:  Yit-Heng Chooi; Peng Wang; Jinxu Fang; Yanran Li; Katherine Wu; Pin Wang; Yi Tang
Journal:  J Am Chem Soc       Date:  2012-05-25       Impact factor: 15.419

Review 3.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

4.  Recent Advances on Small-Molecule Survivin Inhibitors

Authors:  Min Xiao; Wei Li
Journal:  Curr Med Chem       Date:  2015-01-13       Impact factor: 4.530

5.  Marasmius oreades substances block NF-kappaB activity through interference with IKK activation pathway.

Authors:  Roumyana D Petrova; Jamal Mahajna; Solomon P Wasser; Nili Ruimi; Cvetomir M Denchev; Sherbel Sussan; Eviatar Nevo; Abraham Z Reznick
Journal:  Mol Biol Rep       Date:  2008-04-04       Impact factor: 2.316

Review 6.  Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.

Authors:  Yinzhi Lin; Tamami Ukaji; Naoki Koide; Kazuo Umezawa
Journal:  Int J Mol Sci       Date:  2018-03-03       Impact factor: 5.923

Review 7.  Anticancer Activity of Novel NF-kappa B Inhibitor DHMEQ by Intraperitoneal Administration.

Authors:  Kazuo Umezawa; Andrzej Breborowicz; Shamil Gantsev
Journal:  Oncol Res       Date:  2020-06-23       Impact factor: 5.574

Review 8.  Anticancer Activities of Mushrooms: A Neglected Source for Drug Discovery.

Authors:  Sujogya Kumar Panda; Gunanidhi Sahoo; Shasank S Swain; Walter Luyten
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-31

9.  Anti-inflammatory properties of mutolide isolated from the fungus Lepidosphaeria species (PM0651419).

Authors:  Meet Shah; Sunil Kumar Deshmukh; Shilpa A Verekar; Akash Gohil; Abhijeet S Kate; V Rekha; Asha Kulkarni-Almeida
Journal:  Springerplus       Date:  2015-11-19

10.  Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer.

Authors:  Ritu Arora; Clayton Yates; Bernard D Gary; Steven McClellan; Ming Tan; Yaguang Xi; Eddie Reed; Gary A Piazza; Laurie B Owen; Windy Dean-Colomb
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.